Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease. 12 min read What Is Cystic Fibrosis? Cystic ...

Background Cystic fibrosis (CF) is an incurable, progressive disease that affects multiple organs, causing burdensome symptoms. This study aimed to explore the palliative care needs in patients with ...

BACKGROUND Patients with cystic fibrosis (CF) have many risk factors for reduced bone mineral density (BMD). The aim of this study was to determine the prevalence of osteoporosis and osteopenia in a ...

Background Cystic fibrosis (CF) is a complex disorder with multisystem involvement. Although we used to believe that an association between CF and food allergies is rare and more frequently a false ...

A 3-year clinical training program for pediatric and adult gastroenterologists named DIGEST (Developing Innovative Gastrointestinal Specialty Training) was created to address gastrointestinal (GI) ...

BACKGROUND Cystic fibrosis is characterised by oxidative stress in the airways. Isoprostanes are prostaglandin isomers formed by free radical catalysed peroxidation of arachidonic acid. 8-Isoprostane ...

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate ...

Background Outcome reporting bias (ORB ... The aim of this study was to assess ORB across all efficacy outcomes in the Cochrane systematic reviews of cystic fibrosis. Methods Systematic reviews of ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

Background The effect of complex alleles in cystic fibrosis (CF) is poorly defined for the lack of functional studies. Methods We studied 70 homozygous, compound heterozygous or heterozygous for CFTR ...

a Department of Gastroenterology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10, UK, b Department of Cystic Fibrosis, The Royal Brompton Hospital, Sydney Street, London SW3 Dr D ...

Background Inhaled hypertonic saline (HTS) improves quality of life and reduces pulmonary exacerbations when given long term in patients with cystic fibrosis (CF). While increasingly being offered for ...